Notification
No new Notification messages
Zinka Logistics Solutions IPO is Open!
Apply for the Zinka Logistics Solutions IPO through UPI in just minutes.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
kimia biosciences limited stock

KIMIA BIOSCIENCES LIMITED Share Price

46.29 -0.68 (-1.44%)
Nov 21 2024 02:06 PM Pharmaceuticals NSE: KIMIABL

KIMIA BIOSCIENCES LIMITED Share Price Update

As of the latest trading session, KIMIA BIOSCIENCES LIMITED share price is currently at 46.29, which is down by -0.68 from its previous closing. Today, the stock has fluctuated between 45.55 and 47.95. Over the past year, KIMIA BIOSCIENCES LIMITED has achieved a return of 25.17 %. In the last month alone, the return has been -4.60 %. Read More...

KIMIA BIOSCIENCES LIMITED Performance

Day Range

Low45.55 High47.95
46.29

52 Week Range

Low 33.20 High 58.40
46.29

KIMIA BIOSCIENCES LIMITED Share Price

530313

KIMIABL

img img img img
No Data Available

Open Price

46.98

Prev. Close

46.98

Volume (Shares)

773.00

Total traded value

.35

Upper Circuit

56.37

Lower Circuit

37.59

Note: The current prices & values are delayed, Login to your account for live updates.

KIMIA BIOSCIENCES LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 219.00
PE Ratio (TTM) 77.02
Book Value / Share 0.71
Beta 0.61
ROE 0.00%
EPS (TTM) 0.61
Dividend Yield 0.00%
Net Profit Qtr (Cr) 1.61

KIMIA BIOSCIENCES LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 28.18
Operating Expense 26.64
Net Profit 1.61
Net Profit Margin (%) 5.71
Earnings Per Share (EPS) 0.34
EBITDA 3.74
Effective Tax Rate (%) 15.70
Particulars JUN 2024 (Values in Cr)
Revenue 22.40
Operating Expense 20.70
Net Profit 1.44
Net Profit Margin (%) 6.42
Earnings Per Share (EPS) 0.30
EBITDA 3.79
Effective Tax Rate (%) 19.66
Particulars MAR 2024 (Values in Cr)
Revenue 30.30
Operating Expense 28.30
Net Profit 1.80
Net Profit Margin (%) 5.94
Earnings Per Share (EPS) 0.38
EBITDA 4.47
Effective Tax Rate (%) 22.07
Particulars DEC 2023 (Values in Cr)
Revenue 26.14
Operating Expense 29.32
Net Profit -1.95
Net Profit Margin (%) -7.45
Earnings Per Share (EPS) -0.41
EBITDA -0.47
Effective Tax Rate (%) 25.00
Particulars SEP 2023 (Values in Cr)
Revenue 24.20
Operating Expense 28.10
Net Profit -2.44
Net Profit Margin (%) -10.08
Earnings Per Share (EPS) -0.52
EBITDA -1.33
Effective Tax Rate (%) 25.07
Particulars MAR 2024 (Values in Cr)
Revenue 104.88
Operating Expense 113.70
Net Profit -5.31
Net Profit Margin (%) -5.06
Earnings Per Share (EPS) -1.12
EBITDA 1.16
Effective Tax Rate (%) 26.18
Particulars MAR 2023 (Values in Cr)
Revenue 128.52
Operating Expense 141.07
Net Profit -9.35
Net Profit Margin (%) -7.27
Earnings Per Share (EPS) -1.98
EBITDA -4.81
Effective Tax Rate (%) 24.53
Particulars MAR 2022 (Values in Cr)
Revenue 124.90
Operating Expense 130.85
Net Profit -3.70
Net Profit Margin (%) -2.96
Earnings Per Share (EPS) -0.78
EBITDA 1.56
Effective Tax Rate (%) 26.29
Particulars MAR 2021 (Values in Cr)
Revenue 132.71
Operating Expense 129.64
Net Profit 5.10
Net Profit Margin (%) 3.84
Earnings Per Share (EPS) 1.08
EBITDA 10.83
Effective Tax Rate (%) 7.77
Particulars MAR 2020 (Values in Cr)
Revenue 106.29
Operating Expense 106.03
Net Profit 1.38
Net Profit Margin (%) 1.29
Earnings Per Share (EPS) 0.32
EBITDA 5.42
Effective Tax Rate (%) -13.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 1.15
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 4.60
EBITDA Margin -3.74
Particulars MAR 2022 (Values in Cr)
Book Value / Share 3.15
ROE % -22.20
ROCE % -2.03
Total Debt to Total Equity 2.57
EBITDA Margin 1.25
Particulars MAR 2021 (Values in Cr)
Book Value / Share 3.90
ROE % 32.16
ROCE % 13.88
Total Debt to Total Equity 2.48
EBITDA Margin 8.17
Particulars MAR 2020 (Values in Cr)
Book Value / Share 2.86
ROE % 14.73
ROCE % 7.65
Total Debt to Total Equity 3.31
EBITDA Margin 5.10
Particulars MAR 2019 (Values in Cr)
Book Value / Share 2.39
ROE % 79.42
ROCE % 14.46
Total Debt to Total Equity 7.63
EBITDA Margin 7.35
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.49
Total Assets 121.31
Total Liabilities 121.31
Total Equity 5.46
Share Outstanding 47312741
Price to Book Ratio 28.26
Return on Assets (%) -7.70
Return on Capital (%) -16.02
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.51
Total Assets 109.49
Total Liabilities 109.49
Total Equity 14.88
Share Outstanding 47312741
Price to Book Ratio 11.94
Return on Assets (%) -3.38
Return on Capital (%) -6.67
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.67
Total Assets 106.66
Total Liabilities 106.66
Total Equity 18.43
Share Outstanding 47312741
Price to Book Ratio 9.73
Return on Assets (%) 4.78
Return on Capital (%) 8.06
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.77
Total Assets 85.66
Total Liabilities 85.66
Total Equity 13.37
Share Outstanding 46353951
Price to Book Ratio 6.99
Return on Assets (%) 1.61
Return on Capital (%) 3.14
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 1.26
Total Assets 65.39
Total Liabilities 65.39
Total Equity 6.10
Share Outstanding 14594420
Price to Book Ratio 14.87
Return on Assets (%) 5.89
Return on Capital (%) 10.82
Particulars MAR 2023 (Values in Cr)
Net Income -12.38
Cash from Operations -6.78
Cash from Investing -2.79
Cash from Financing 9.54
Net change in Cash -0.02
Free Cash Flow -3.97
Particulars MAR 2022 (Values in Cr)
Net Income -5.01
Cash from Operations 8.06
Cash from Investing -0.71
Cash from Financing -7.66
Net change in Cash -0.38
Free Cash Flow 11.64
Particulars MAR 2021 (Values in Cr)
Net Income 5.53
Cash from Operations 5.92
Cash from Investing -13.60
Cash from Financing 7.99
Net change in Cash 0.35
Free Cash Flow 19.48
Particulars MAR 2020 (Values in Cr)
Net Income 1.22
Cash from Operations 0.23
Cash from Investing -8.62
Cash from Financing 8.45
Net change in Cash 0.13
Free Cash Flow 9.24
Particulars MAR 2019 (Values in Cr)
Net Income 3.80
Cash from Operations -2.49
Cash from Investing -2.22
Cash from Financing 4.41
Net change in Cash -0.45
Free Cash Flow 0.09
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 55.85 32.10 3.04 428.00 37.54 / 77.70
BLISS GVS PHARMA LTD 120.75 15.11 1.25 1271.52 92.25 / 148.95
CIPLA LTD 1471.35 25.74 4.18 118825.56 1165.10 / 1702.00
FERMENTA BIOTECH LIMITED 331.20 115.00 3.35 974.75 145.00 / 354.60
GLAXOSMITHKLINE PHARMA LT 2436.25 51.47 24.67 41271.55 1565.05 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 55.85 48.57 9.49 428.00 37.54 / 77.70
AMRUTAJAN HEALTH LTD 720.90 43.85 6.99 2084.17 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6497.50 126.19 23.91 16243.75 4050.15 / 8139.85
BLISS GVS PHARMA LTD 120.75 15.72 1.24 1271.52 92.25 / 148.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 47.30
  • 26 Days 48.40
  • 10 Days 47.90
  • 50 Days 49.40
  • 12 Days 47.90
  • 100 Days 50.30
  • 20 Days 48.20
  • 200 Days 39.20
47.43
PIVOT
First Resistance 48.05
Second Resistance 49.11
Third Resistance 49.73
First Support 46.37
Second Support 45.75
Third Support 44.69
RSI 45.62
MACD -0.51
Commodity Channel Index (CCI) -64.97
ADX 22.80
Williams % R -54.01

Over 1 Month

down

-4.60

Over 3 Months

down

-4.60

Over 6 Months

down

-0.59

Over 1 Year

down

25.17

Over 3 Years

down

5.24

Over 5 Years

down

12.86

KIMIA BIOSCIENCES LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

KIMIA BIOSCIENCES LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
24.67
Promoter Holdings
74.93
FII
0.0
DII
0.38
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Sameer Goel Shareholding of Promoter and Promoter Group 3.5455776E7 74.94
Rahul Agrawal Public Shareholding 2050000.0 4.33
Anish Kumar Aggarwal Public Shareholding 2050000.0 4.33
Manish Gupta Public Shareholding 2009820.0 4.25
Roma Mittal Public Shareholding 1942288.0 4.11
Vipul Goel Shareholding of Promoter and Promoter Group 16.0 0.0
Vandana Goel Shareholding of Promoter and Promoter Group 16.0 0.0
Santosh Goel Shareholding of Promoter and Promoter Group 32.0 0.0

KIMIA BIOSCIENCES LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About KIMIA BIOSCIENCES LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by KIMIA BIOSCIENCES LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Kimia Biosciences Ltd?

Answer Field

The share price of Kimia Biosciences Ltd for NSE is ₹ 0.00 and for BSE is ₹ 46.29.

What is the Market Cap of Kimia Biosciences Ltd?

Answer Field

The market cap of Kimia Biosciences Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 2,19.00 Cr. as of now.

What is the 52 Week High and Low of Kimia Biosciences Ltd?

Answer Field

The 52 Week High and Low of Kimia Biosciences Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 58.40 and ₹ 33.20.

How to Buy Kimia Biosciences Ltd share?

Answer Field

You can trade in Kimia Biosciences Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Kimia Biosciences Ltd?

Answer Field

The 1 year returns on the stock has been 25.17%.

What is the Current Share Price of Kimia Biosciences Ltd?

Answer Field

Kimia Biosciences Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 46.29 as on Nov 21 2024 02:06 PM.

What is the Market Cap of Kimia Biosciences Ltd Share?

Answer Field

The market cap of Kimia Biosciences Ltd for NSE ₹ 0.0 & for BSE ₹ 2,19.00 as on Nov 21 2024 02:06 PM.

What is the P/E Ratio of Kimia Biosciences Ltd Share?

Answer Field

As on Nov 21 2024 02:06 PM the price-to-earnings (PE) ratio for Kimia Biosciences Ltd share is 77.02.

What is the PB ratio of Kimia Biosciences Ltd Share?

Answer Field

As on Nov 21 2024 02:06 PM, the price-to-book (PB) ratio for Kimia Biosciences Ltd share is 0.71.

How to Buy Kimia Biosciences Ltd Share?

Answer Field

You can trade in Kimia Biosciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Kimia Biosciences Ltd Share on Bajaj Broking App?

Answer Field

To buy Kimia Biosciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Kimia Biosciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader